Preclinical services from a top pre-clinical CRO in Kiev, UA.
Our company is an independent Contract Research Organization operating out of the USA that provides preclinical drug trials in state-of-the art, GLP certified research laboratories in Kiev, UA. Our testing facilities are sponsored by the UNAMS and Ministry of Health and provide support for for-profit development of new drug discoveries as part of their core mission. The CRO was created to provide the top-notch, inexpensive services of these laboratories to start-up biotech companies in the United States and EU, thereby offering a smart option for promoting development programs quickly and at much lower cost than other commercial Contract Research Organizations. We offer a broad range of preclinical testing including drug safety, acute and chronic toxicity, pharmacological screening, bio-availability , bioequivalence, and full in vivo and in vitro screening for anti-cancer activity.
Our preclinical Contract Research Organization is able to price preclinical toxicology far below other Contract Research Organizations because we maintain a very low overhead in the U.S. and conduct all research in Kiev where personnel and lab costs are much lower. Our team in the USA is comprised of only of the organization principals who work directly with customers; we have no marketing costs aside from our site, and no main offices, administrative staff or other overhead to inflate costs. We have much lower research conduct costs in Kiev due to much lower personnel rates and are able to offer our best pricing for long-term and more complex pre-clinical tests where labor is the greatest portion of the overall price. Since we use the same stable international providers for animal models, reagents and lab materials as other Contract Research Organizations, we don’t have any cost savings on these materials and so less overall cost savings for very short-term pre-clinical trials. However, regardless of your test protocol and duration, our goal is to provide our customers the greatest possible value for their money.